I

Inflammatix, Inc.

98 employees

Inflammatix develops novel molecular diagnostics for acute infections and sepsis that work by reading the immune system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Computational Immunology
Molecular Diagnostics
Big Data
Personalized Medicine
in-vitro diagnostics
Bioinformatics

Date founded

2016

Funding rounds raised

Total raised

$102M

from 11 investors over 11 rounds

I

Inflammatix, Inc. raised $1.7M on November 11, 2021

Investors: National Institutes of Health

I

Inflammatix, Inc. raised $102M on March 16, 2021

Investors: Northpond Ventures, D1 Capital Partners L.P. and Khosla Ventures

I

Inflammatix, Inc. raised $1.1M on September 29, 2020

Investors: Darpan Dance Company

I

Inflammatix, Inc. raised $32M on January 10, 2020

Investors: Northpond Ventures, Khosla Ventures and Grey Sky Venture Partners

I

Inflammatix, Inc. raised undisclosed on October 18, 2018

Investors: Northpond Ventures

I

Inflammatix, Inc. raised undisclosed on March 17, 2017

Investors: Khosla Ventures

I

Inflammatix, Inc. raised $1M on January 20, 2017

Investors: Darpan Dance Company

FAQ